Original Article Shrna-Mediated Silencing of PKHD1 Gene Promotes Proliferation, Migration and Invasion of Human Intrahepatic Cholangiocarcinoma Hucct-1 Cells

Total Page:16

File Type:pdf, Size:1020Kb

Original Article Shrna-Mediated Silencing of PKHD1 Gene Promotes Proliferation, Migration and Invasion of Human Intrahepatic Cholangiocarcinoma Hucct-1 Cells Int J Clin Exp Pathol 2017;10(3):2496-2509 www.ijcep.com /ISSN:1936-2625/IJCEP0044430 Original Article shRNA-mediated silencing of PKHD1 gene promotes proliferation, migration and invasion of human intrahepatic cholangiocarcinoma HuCCT-1 cells Su Lin1, Cheng He1, Min-Fang Wang1, Yin-Lian Wu1, Jian Lin2, Yi Liu3, Yue-Yong Zhu1 1Liver Research Center, 2Department of Hepato-Biliary-Pancreatic Surgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian Province, China; 3Department of Gastroenterology, Huashan Hospital of Fudan University, Shanghai, China Received November 16, 2016; Accepted January 7, 2017; Epub March 1, 2017; Published March 15, 2017 Abstract: Intrahepatic cholangiocarcinoma (ICC), a type of cholangiocarcinoma, is characterized by insidious onset and lack of typical clinical symptoms at early onset, and the lack of effective treatments results in a poor prognosis. Identification of novel biomarkers and treatment targets is therefore of great significance to improve the survival for ICC patients. Polycystic kidney and hepatic disease 1 (PKHD1), a gene responsible for autosomal recessive poly- cystic kidney disease (ARPKD), has been linked to cancers, and mutation of the PKHD1 gene may cause abnormal proliferation and differentiation of bile duct epithelial cells. However, the role of the PKHD1 gene in the biological be- haviors of ICC cells remains unknown until now. The present study was therefore designed to examine the effects of PKHD1 knockdown on the proliferation, migration and invasion of human ICC HuCCT-1 cells and investigate the un- derlying mechanisms. We transfected a lentiviral vector LV3-PKHD1 that contained the short hairpin RNA (shRNA)- mediated silencing of the PKHD1 gene into HuCCT-1 cells, while GFP lentiviral vector LV3NC-transfected cells served as negative controls. The cell proliferation, migration and invasion were measured, and the ultrastructure of primary cilium was observed using scanning electron microscopy (SEM). The expression of PI3K/Akt signaling proteins was determined with Western blotting. qRT-PCR assay determined down-regulation of PKHD1 mRNA expression and Western blotting analysis revealed reduced FPC expression in HuCCT-1 cells post-transfection with LV3-PKHD1, which validated the effective silencing of the PKHD1 gene in HuCCT-1 cells. Wound scratch assay showed that the LV3-PKHD1 transfected HuCCT-1 cells had a greater healing ability of the scratch than the LV3NC-transfected and nontransfected cells at 24 and 48 h, and CCK-8 assay revealed that the LV3-PKHD1 transfected HuCCT-1 cells exhibited a greater proliferative ability than the LV3NC-transfected and nontransfected cells (P < 0.01). In addition, Transwell migration assay showed significantly more LV3-PKHD1 transfected HuCCT-1 cells penetrating through the Transwell chamber than the LV3NC-transfected and nontransfected cells (P < 0.01), and Transwell invasion assay revealed more LV3-PKHD1 transfected HuCCT-1 cells crossing the Matrigel than the LV3NC-transfected and nontransfected cells (P < 0.01). Moreover, Western blotting assay detected significant up-regulation of PI3K, Akt, p-Akt, and NF-κB expression in LV3-PKHD1 transfected HuCCT-1 cells as compared to that in the LV3NC-transfected and nontransfected cells (P < 0.05), and SEM displayed shorter length, less number and lower distribution density of primary cilium on the surface of LV3-PKHD1 transfected HuCCT-1 cells relative to LV3NC-transfected cells. The results of this study demonstrate that the silencing of the PKHD1 gene promotes the proliferation, migration and invasion of human ICC HuCCT-1 cells via the PI3K/Akt signaling pathway. Keywords: Intrahepatic cholangiocarcinoma, PKHD1, proliferation, migration, invasion, PI3K/Akt signaling, gene silencing Introduction only to hepatocellular carcinoma (HCC) in all hepatobiliary malignancies and comprises Cholangiocarcinoma is a primary bile tract approximately 3% of all gastrointestinal tumors malignant tumor that originates from the bile [2]. This malignancy is found to be highly preva- duct epithelial cells [1]. The incidence of chol- lent in people at ages of approximately 70 angiocarcinoma is estimated to rank second years, with a bit higher incidence in men than in PKHD1 silencing promotes HuCCT-1 cell proliferation, migration and invasion women [2]. Epidemiological data show an ongo- invasion of human ICC HuCCT-1 cells and inves- ing rise in both the incidence and mortality of tigate the underlying mechanisms, so as to pro- cholangiocarcinoma worldwide [3]. vide new insights into the screening of novel targets for the treatment of ICC. Cholangiocarcinoma is anatomically classified into three groups, intrahepatic, perihilar, and Materials and methods distal [4]. Intrahepatic cholangiocarcinoma (ICC) originates from the intrahepatic bile duct Cell lines and culture and its branch to the interlobular ductile, which is characterized by insidious onset and lack of Human ICC HuCCT-1 cell lines were purchased typical clinical symptoms at early onset [5-7]. from Riken (Kyoto, Japan), and GFP lentiviral Since the currently available diagnostic tools vector LV3NC (target sequence: TTCTCCGAAC- show a low sensitivity and there is a lack of GTGTCACGT) transfected HuCCT-1 cells were specific biomarkers, most cases with ICC are provided by the Shanghai GenePharma Biotech identified as a late stage or having severe com- Company (Shanghai, China). The lentiviral vec- plications upon definite diagnosis [8]. Surgical tor LV3-PKHD1 (target sequence: AAGCAGT- resection and liver transplantation remain the CCAAATCCAGGACC) that contained the short most effective approaches for the treatment of hairpin RNA (shRNA)-mediated silencing of the ICC; however, surgical therapy has a low com- PKHD1 gene was constructed in vitro by the plete resection rate, which achieves 10% to Shanghai GenePharma Biotech Company 30% 5-year survival rate post-surgery [9], and (Shanghai, China), and the LV3-PKHD1 was there is a huge lack of matched liver donors for transfected into HuCCT-1 cells to construct sta- liver transplantation which suffers from a great bly transfected HuCCT-1 cells with low PKHD1 deal of money [10-12]. Screening and identifi- expression. Both vectors contained GFP. All cell cation of novel biomarkers for early diagnosis lines were maintained in the Dulbecco’s modi- and prognosis prediction is therefore of great fied Eagle’s medium (DMEM; Gibco, Carlsbad, significance to improve the survival in ICC CA, USA) supplemented with 10% fetal bovine patients, which is urgently needed. serum (FBS; Gibco, Carlsbad, CA, USA), 1.5 mM L-glutamine (Hyclone; Logan, UT, USA), 100 U/ Polycystic kidney and hepatic disease 1 (PK- ml penicillin(Hyclone; Logan, UT, USA) and 100 HD1), a gene responsible for autosomal reces- μg/ml streptomycin (Hyclone; Logan, UT, USA) sive polycystic kidney disease (ARPKD), is at 37°C containing 5% CO2. encoded by the membrane-associated recep- tor-like protein fibrocystin/polyductin (FPC), Wound scratch assay which is composed of 4074 amino acids [13- 15]. PKHD1 gene is expressed at a high level in Six culture inserts (Ibidi GmbH; Munich, Ger- the kidney and at lower levels in the liver and many) were placed in the center of a 24-well pancreas [16-18], while the PFC protein is plate (Corning Inc.; Corning, NY, USA), and were mainly distributed on the primary cilia and api- divided into 3 groups, of two inserts for each cal membrane in the bile duct, which is involved group. Log-phase, LV3NC-transfecteds and LV3- in the maintenance of the normal tubular struc- PKHD1-transfected HuCCT-1 cells were seeded ture of the intrahepatic bile duct epithelial cells onto culture inserts at a density of 3.5 × 104 [19]. Mutation of the PKHD1 gene has been cells in each insert, respectively. Cells were cul- shown to cause abnormal proliferation and dif- tured overnight at 37°C in a saturated humidity ferentiation of bile duct epithelial cells [20], incubator containing 5% CO2 (Thermo Fisher and the morphological defect of primary cilium Scientific; Cleveland, OH, USA). Then, the cul- and defective cilium-mediated intracellular sig- ture inserts were gently removed with a sterile nal transduction may lead to cell cycle abnor- forceps, and a scratch with 500 μm in width mality and benign cell over-proliferation, result- was produced. Each well that contained an ing in cyst formation and enlargement [21, 22]. insert was slowly transferred with approximate- However, the role of the PKHD1 gene in the bio- ly 500 μl fresh medium through the plate wall, logical behaviors of ICC cells remains unknown and the changes of scratches in the culture until now. The present study was therefore plate was observed once every 4 to 6 h under designed to examine the effects of PKHD1 an inverted microscope (Zeiss; Oberkochen, knockdown on the proliferation, migration and German), and photographed. 2497 Int J Clin Exp Pathol 2017;10(3):2496-2509 PKHD1 silencing promotes HuCCT-1 cell proliferation, migration and invasion CCK-8 assay let solution for 20 min, washed with clean water and photographed. Log-phase, LV3NC-transfecte and LV3-PKHD1- transfected HuCCT-1 cells were harvested, Scanning electron microscopy (SEM) digested with 0.25% trypsin (Hyclone; Logan, UT, USA) and prepared into single-cell suspen- Sterile coverslips measuring 0.5 cm × 0.5 cm sions. Cells were seeded onto 96-well plates at were transferred to 24-well plates. Log-phase, a density of 2000 cells in each well and incu- LV3NC-transfected and LV3-PKHD1 transfect- bated overnight. Then, each cell-contained well ed-HuCCT-1 cells were digested with 0.25% was transferred quickly with 10 μl CCK-8 solu- trypsin and prepared into single-cell suspen- tion along the plate wall, and gently shook for sions. Cells were then seeded onto 24-well 4 completely even mixture. Following 2 h incuba- plates at 2 × 10 cells per well and incubated tion, the absorbance was measured at 260 nm overnight at 37°C containing 5% CO2. When with a NanoDrop2000 UV-Vis spectrophotome- cells were adherent to the plate wall, they were ter (Thermo Fisher Scientific; Cleveland, OH, rinsed gently with PBS to remove the dead USA).
Recommended publications
  • Article Case Report Congenital Hepatic Fibrosis
    Article Case report Congenital hepatic fibrosis: case report and review of literature Brahim El Hasbaoui, Zainab Rifai, Salahiddine Saghir, Anas Ayad, Najat Lamalmi, Rachid Abilkassem, Aomar Agadr Corresponding author: Zainab Rifai, Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco. [email protected] Received: 19 Jan 2021 - Accepted: 03 Feb 2021 - Published: 18 Feb 2021 Keywords: Fibrosis, hyper-transaminasemia, cholestasis, ciliopathy, case report Copyright: Brahim El Hasbaoui et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cite this article: Brahim El Hasbaoui et al. Congenital hepatic fibrosis: case report and review of literature. Pan African Medical Journal. 2021;38(188). 10.11604/pamj.2021.38.188.27941 Available online at: https://www.panafrican-med-journal.com//content/article/38/188/full Congenital hepatic fibrosis: case report and review &Corresponding author of literature Zainab Rifai, Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, Brahim El Hasbaoui1, Zainab Rifai2,&, Salahiddine University Mohammed V, Rabat, Morocco Saghir1, Anas Ayad1, Najat Lamalmi3, Rachid 1 1 Abilkassem , Aomar Agadr 1Department of Pediatrics, Military Teaching Hospital Mohammed V, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco, 2Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco, 3Department of Histopathologic, Avicenne Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco Article characterized histologically by defective Abstract remodeling of the ductal plate (DPM).
    [Show full text]
  • Conference 1 C O N F E R E N C E 16 29 January 2020 18 August, 2021 Dr
    Joint Pathology CeJointnter Pathology Center Veterinary PatholVeterinaryogy Service Pathologys Services WEDNESDAY SLIDE CONFERENCE 2021-2022 WEDNESDAY SLIDE CONFER ENCE 2019-2020 Conference 1 C o n f e r e n c e 16 29 January 2020 18 August, 2021 Dr. Ingeborg Langohr, DVM, PhD, DACVP Professor Department of Pathobiological Sciences Louisiana S tate University School of Veterinary Medicine Baton RouJointge, L APathology Center Silver Spring, Maryland CASE I: CASE S1809996 1: 1 ((4152313JPC 4135077-00) ). Microscoptan/purple.ic Descr ipThetio n:medullary The inte rstitparenchymaium was within thedisrupted section isby diff dozensusel yof infilt brightra tedred btoy dull purple SignalmeSignalment:nt: A 3-mont h-old, male, mixed- moderate linesto lar thatge radiatednumbers from of pre thedomi levelna ofntl they renal crest breed pig 6(-Susmonth scrofa-old )male (intact) mastiff (Canis mononuclethroughar cell thes a lonmedulla.g with edema. There familiaris). is abunda nt type II pneumocyte hyperplasia History: This pig had no previous signs of lining alveolar septae and many of the illness, andHistory: was found dead. The patient was referred to a veterinary medicalalveola r spaces have central areas of Gross Patholteachingogy : hospitalApprox imfollowingately 70% an o facute, 1-dayne- crotic macrophages admixed with other the lungs,history primar ofily lethargy in the c andrani ainappetencel regions o fthat quicklymononucle ar cells and fewer neutrophils. the lobes, progressedwere patch toy obtundation. dark red, and Bloodwork firm performedOc casionally there is free nuclear basophilic comparedat to thethe rDVMmore norevealedrmal ar etooas ofhigh lun tog. read ALT, elevated ALP (805 U/L), hypoalbuminemia (2.7 Laboratorg/dL)y re suandlts: hypoglycemia Porcine reprodu (23 cmg/dL).tive PT and and respiraaPTTtory weresyndrome both prolonged (PRRS) PCat >100R wa secs and >300 positive frsec,om sprespectively.lenic tissue, Protein and P RandRS IHCbilirubin were was strongdetectedly immunore on a urineactive dipstick.
    [Show full text]
  • Tepzz 77889A T
    (19) TZZ T (11) EP 2 277 889 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 26.01.2011 Bulletin 2011/04 C07K 1/00 (2006.01) C12P 21/04 (2006.01) C12P 21/06 (2006.01) A01N 37/18 (2006.01) (2006.01) (2006.01) (21) Application number: 10075466.2 G01N 31/00 C07K 14/765 C12N 15/62 (2006.01) (22) Date of filing: 23.12.2002 (84) Designated Contracting States: • Novozymes Biopharma UK Limited AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Nottingham NG7 1FD (GB) IE IT LI LU MC NL PT SE SI SK TR (72) Inventors: (30) Priority: 21.12.2001 US 341811 P • Ballance, David James 24.01.2002 US 350358 P Berwyn, PA 19312 (US) 28.01.2002 US 351360 P • Turner, Andrew John 26.02.2002 US 359370 P King of Prussia, PA 19406 (US) 28.02.2002 US 360000 P • Rosen, Craig A. 27.03.2002 US 367500 P Laytonsville, MD 20882 (US) 08.04.2002 US 370227 P • Haseltine, William A. 10.05.2002 US 378950 P Washington, DC 20007 (US) 24.05.2002 US 382617 P • Ruben, Steven M. 28.05.2002 US 383123 P Brookeville, MD 20833 (US) 05.06.2002 US 385708 P 10.07.2002 US 394625 P (74) Representative: Bassett, Richard Simon et al 24.07.2002 US 398008 P Potter Clarkson LLP 09.08.2002 US 402131 P Park View House 13.08.2002 US 402708 P 58 The Ropewalk 18.09.2002 US 411426 P Nottingham 18.09.2002 US 411355 P NG1 5DD (GB) 02.10.2002 US 414984 P 11.10.2002 US 417611 P Remarks: 23.10.2002 US 420246 P •ThecompletedocumentincludingReferenceTables 05.11.2002 US 423623 P and the Sequence Listing can be downloaded from the EPO website (62) Document number(s) of the earlier application(s) in •This application was filed on 21-09-2010 as a accordance with Art.
    [Show full text]
  • Ep 1 803 730 A1
    (19) & (11) EP 1 803 730 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 04.07.2007 Bulletin 2007/27 C07K 1/00 (2006.01) C07K 14/765 (2006.01) (21) Application number: 06015131.3 (22) Date of filing: 12.04.2001 (84) Designated Contracting States: (74) Representative: Bassett, Richard Simon AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU Eric Potter Clarkson LLP MC NL PT SE TR Park View House 58 The Ropewalk (30) Priority: 12.04.2000 US 229358 P Nottingham NG1 5DD (GB) 25.04.2000 US 199384 P 21.12.2000 US 256931 P Remarks: •This application was filed on 20 - 07 - 2006 as a (62) Document number(s) of the earlier application(s) in divisional application to the application mentioned accordance with Art. 76 EPC: under INID code 62.Claims 34 - 69 are deemed to be 01937179.8 / 1 276 856 abandoned due to non-payment of the claims fees (Rule 3182) EPC). (71) Applicant: HUMAN GENOME SCIENCES, INC. •The sequence listing, which is published as annex Rockville, MD 20850 (US) to the application documents, was filed after the date of filing. The applicant has declared that it does not (72) Inventors: include matter which goes beyond the content of the • Rosen, Craig A. application as filed. Laytonsville, Maryland 20882 (US) • Haseltine, William A. Washington, DC 20007 (US) (54) Albumin fusion proteins (57) The present invention encompasses albumin fu- vectors, and/or host cells. Additionally the present inven- sion proteins. Nucleic acid molecules encoding the albu- tion encompasses pharmaceutical compositions com- min fusion proteins of the invention are also encom- prising albumin fusion proteins and methods of treating, passed by the invention, as are vectors containing these preventing, or ameliorating diseases, disorders or con- nucleic acids, host cells transformed with these nucleic ditions using albumin fusion proteins of the invention.
    [Show full text]
  • Congenital Hepatic Fibrosis and Its Mimics: a Clinicopathologic Study of 19 Cases at a Single Institution Irene Y
    Chen et al. Diagnostic Pathology (2021) 16:81 https://doi.org/10.1186/s13000-021-01142-y RESEARCH Open Access Congenital hepatic fibrosis and its mimics: a clinicopathologic study of 19 cases at a single institution Irene Y. Chen, Christa L. Whitney-Miller and Xiaoyan Liao* Abstract Background: Congenital hepatic fibrosis (CHF) is a rare inherited form of ductal plate malformation associated with polycystic kidney disease. The diagnosis requires histopathologic confirmation, but can be challenging to distinguish from other undefined fibrocystic liver diseases. We aimed to describe the clinicopathologic features of congenital hepatic fibrosis (CHF), with comparisons to other entities that may clinically and/or histologically mimic CHF. Methods: Nineteen cases that carried a clinical and/or histologic impression of CHF were identified at our institution, of which the histology was reassessed and reappraised into two categories: CHF (n=13) and mimics (n=6). The clinicopathologic features between the two groups were analyzed and compared. Results: The CHF group was further sub-classified into those with clinical suspicion (CHF-c, n=8) and those as incidental histology findings (CHF-i, n=5). Patients of CHF-i were much older than CHF-c or mimics (P<0.05). Male and female were equally affected. Six of 8 CHF-c (66.7%) had concurrent kidney diseases, including 5 polycystic kidney diseases. Five of 6 mimics (83.3%) had various kidney diseases, including nephronophthisis, Alport syndrome, renal agenesis, and nephrolithiasis. None of the CHF-i patients had kidney disease, but 3 were associated with hepatic carcinomas. Histology analysis demonstrated characteristic triads (bile duct abnormalities, portal vein hypoplasia, and fibrosis) in all CHF cases.
    [Show full text]
  • Original Article Imaging Findings of Bile Duct Hamartomas: a Case Report and Literature Review
    Int J Clin Exp Med 2015;8(8):13145-13153 www.ijcem.com /ISSN:1940-5901/IJCEM0012001 Original Article Imaging findings of bile duct hamartomas: a case report and literature review Qiu-Sheng Shi1*, Ling-Xi Xing1*, Li-Fang Jin1, Han Wang2, Xiu-Hong Lv3, Lian-Fang Du1 1Department of Ultrasound, Shanghai First People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; 2Department of Radiology, Shanghai First People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China; 3Department of Pathology, Shanghai First People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China. *Co-first authors. Received June 27, 2015; Accepted August 11, 2015; Epub August 15, 2015; Published August 30, 2015 Abstract: Bile duct hamartomas (BHs), also called von Meyenburg complex (VMC), are benign biliary malformations that originate from disorganization of the small intrahepatic bile ducts. This disorganization is often associated with the abnormal involution of embryonic ductal end plates in the liver. This is clinically significant, as the development of BHs can cause diagnostic confusion with liver metastases and small hepatocellular carcinoma (SHCC). Currently, we report a specific case of BHs and review the literature to better define and diagnose BHs. In the following case, a 37 year-old male bearing a lesion in his liver is presented and undergoes both radiological and pathological diag- nosis. The lesion is preliminarily suspected to be a hepatic hemangioma by examination of conventional ultrasound (US), contrast enhanced ultrasound (CEUS), computerized tomographic scanning (CT) and magnetic resonance imaging (MRI).
    [Show full text]
  • Congenital Hepatic Fibrosis and Obliterative Portal Venopathy Without Portal Hypertension – a Review of Literature Based on an Asymptomatic Case
    AG-2018-42 ORIGINAL ARTICLE dx.doi.org/10.1590/S0004-2803.201800000-91 Congenital hepatic fibrosis and obliterative portal venopathy without portal hypertension – a review of literature based on an asymptomatic case Juliana Arrais GUERRA1, Kátia Cristina KAMPA1, Maurício ZAPPAROLI2, Venâncio A F ALVES3,4 and Cláudia Alexandra Pontes IVANTES1 Received 14/3/2018 Accepted 8/9/2018 ABSTRACT – The disease and the case reported here are relevant especially because of their varied clinical presentation, possibility of being associated with other disorders affecting several organs and possible differential diagnoses. Congenital Hepatic Fibrosis is an autosomal recessive disease due to mutation in the PKHD1 gene, which encodes the fibrocystin/polyductine protein. It is a cholangiopathy, characterized by varying degrees of peripor- tal fibrosis and irregular proliferation of bile ducts. Affected patients are typically diagnosed in childhood, but in some cases the disease may remain asymptomatic for many years. The exact prevalence and incidence of the disease are not known, but it is consider a rare disease, with a few hundred cases described worldwide. It can affect all ethnic groups and occur associated with various hereditary and non-hereditary disorders. The clinical presentation is quite variable, with melena and hematemesis being initial symptoms in 30%-70% of the cases. More rarely, they may present episodes of cholangitis. The disease has been classified into four types: portal hypertension, cholestasis / cholangitis, mixed and latent. Diagnosis begins with imaging tests, but the definition is made by the histopathological sample. So far, there is no specific therapy that can stop or reverse the pathological process.
    [Show full text]
  • Biliary Duct Hamartomas
    medRxiv preprint (which wasnotcertifiedbypeerreview) NOTE: Thispreprint reportsnewresearchthathasnot beencertifiedbypeerreviewand shouldnotbeusedtoguideclinical practice. Title: Biliary Duct Hamartomas: A Systematic Review Abu Baker Sheikh1, Rahul Shekhar2, Nismat Javed3, Katarina Leyba4, Abdul Ahad Ehsan Sheikh5, Shubhra Upadhyay6, Devika 7 8 9 Kapuria , Christopher Cormier , Tarun Rustagi doi: 1. MD, Resident Physician, University of New Mexico Health Sciences Center, Department of Internal Medicine, Albuquerque, https://doi.org/10.1101/2021.04.27.21256209 NM, USA. Email: [email protected]. 2. MD, Assistant Professor, Division of Hospital Medicine, University of New Mexico Health Sciences Center, Department of Internal Medicine, Albuquerque, NM, USA. Email: [email protected]. It ismadeavailableundera 3. MBBS, Shifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan. Email: [email protected]. 4. Medical Student, University of New Mexico, Department of Internal Medicine, Albuquerque, NM, USA. Email: istheauthor/funder,whohasgrantedmedRxivalicensetodisplaypreprintinperpetuity. [email protected]. 5. MD, Resident Physician, The Wright Center for Graduate Medical Education, Department of Internal Medicine, Scranton, PA, USA. Email: [email protected]. 6. MD, Resident Physician, University of New Mexico Health Sciences Center, Department of Internal Medicine, Albuquerque, NM, USA. Email: [email protected]. CC-BY-NC-ND 4.0Internationallicense ; 7. MD, Clinical Fellow Department of Gastroenterology and Hepatology, University of New Mexico Health Science Center, this versionpostedApril30,2021. Albuquerque, NM, USA. Email: [email protected]. 8. MD, Resident Physician Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA. Email: [email protected]. 9. MD, Interventional Endoscopist & Assistant Professor Division of Gastroenterology and Hepatology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
    [Show full text]
  • Focal Liver Lesion Mohamed Alassas, MD Case • 45 Yo Female Presented with Recurrent RUQ Abdominal Pain
    The 14th Annual Cardiovascular & Medicine Symposium Renaissance World Golf Village Resort, St. Augustine, Florida Focal Liver Lesion Mohamed Alassas, MD Case • 45 yo female presented with recurrent RUQ abdominal pain. Normal exam and lab investigations • US of the abdomen shows multiple gallbladder stones. Also showed a 3 cm solid, well-defined, uniformly echogenic liver mass Focal Liver Lesion • How to identify and diagnose the radiologic finding? • What are the diagnostic tools? • What is the management of the liver lesion? resection or intervention vs observation Focal Liver Lesion The differential diagnosis of focal liver lesions includes a broad spectrum of benign, malignant, and infectious etiologies Differential Diagnosis • Cystic vs solid lesion • Benign vs malignant • Hemangioma is the most common benign lesion • Metastatic neoplasm is the most common malignant lesion Differential Diagnosis • Focal Fatty infiltration • Simple Cyst • Hemangioma • Focal Nodular Hyperplasia • Adenoma • Metastatic lesion • Hepatocellular Carcinoma • Cholangiocarcinoma • Cirrhotic nodule • Pyogenic abscess • Amebic abscess • Hydatid cyst Differential Diagnosis Points in clinical history to narrow D.D. • Age • Gender • Use of oral contraceptives • Presence of Cirrhosis • Fever • Travel history • Extrahepatic malignancy Tumor Markers Alpha fetoprotein • Alpha globulin normally present in high concentration in fetal blood • Elevated in 60-70% of HCC • Elevated in acute and chronic hepatitis and germ cell tumors • Levels above 200 mcg/L are 99% specific
    [Show full text]
  • The Anatomical Pathology Manual a Handbook and Guide for Residents
    The Anatomical Pathology Manual A Handbook and Guide for Residents Dr. Carolin J. Teman, MD FCAP FRCPC Version 2 – published 05 September 2019 2019-2020 RESIDENCY TRAINING in Anatomical Pathology ____________________________________________________________________________________ Table of Contents Section 1: Welcome and Introduction .................................................................................. 6 Section 1.1: Overview..................................................................................................... 6 Section 1.2: Blueprint for Success in Anatomical Pathology .................................................. 7 Section 1.3: Resources ................................................................................................. 10 Section 1.4: General Structure and Content of the Program ................................................ 11 PGY 1 (13 blocks): Basic Clinical Training ....................................................................... 11 PGY 2 (13 blocks): Anatomical Pathology ....................................................................... 11 PGY 3/PGY 4/PGY5 (39 blocks) ..................................................................................... 11 Section 1.5: Royal College of Physicians and Surgeons of Canada (RCPSC) ............................ 13 GENERAL STANDARDS OF ACCREDITATION – A STANDARDS ....................................................... 13 National Standards for Training PRIOR to July 1, 2019 (Traditional Program Stream) ........... 13 National
    [Show full text]
  • Download (2MB)
    Proceeding Book The 18th National Congress & Annual Scientific Meeting Indonesian Association of Pathologist 2015 Diagnostic Challenges and Updates in Gastrointestinal & Liver Pathology in conjunction with APSMI Annual Meeting 2015 Molecular Pathology & Clinical Updates Hotel Tentrem, 20-22 November 2015 UGM Press 2015 Proceeding Book The 18th National Congress & Annual Scientific Meeting Indonesian Association of Pathologist 2015 Diagnostic Challenges and Updates in Gastrointestinal & Liver Pathology in conjunction with APSMI Annual Meeting 2015 Molecular Pathology & Clinical Updates Hotel Tentrem, 20-22 November 2015 Editors dr. Harijadi, Sp.PA (K) dr, Irianiwati, Sp.PA (K) dr. Hanggoro Tri Rinonce, Sp.PA, PhD dr. Brian Wasita, PhD dr. Novan Adi Setiawan dr. Intannuary Paringga Copyright ©2015 UGM Press Perpustakaan Nasional: Katalog Dalam Terbitan (KDT) ISBN 978-602-386-023-4 First edition, 2015 Publisher: UGM Press Jl. Grafika No.1, Kampus UGM, Bulaksumur, Yogyakarta 55281 Telp. 0274-561037 EXT.17 Fax. 0274-561037 Website: http://gmup.ugm.ac.id/ © All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher TABLE OF CONTENT Cover .................................................................................................................................................... 1 Table of Content .............................................................................................................................................. 3 Welcome Remarks by the Chairman
    [Show full text]
  • Systemic Pathology Objectives
    GRIPE Systemic Pathology Index Systemic Pathology Objectives 2004-2005* Topic** Page 61 – HEART 3 62 – VESSELS 7 63 – HEMATOPOIETIC SYSTEM 11 64 – RESPIRATORY SYSTEM 19 71 – ORAL REGION 27 72 – ALIMENTARY TRACT 29 73 – LIVER AND BILIARY TRACT 33 74 – PANCREAS 37 82 – LOWER URINARY TRACT 43 83 – MALE GENITAL SYSTEM 45 84 – FEMALE GENITAL SYSTEM 47 85 – BREAST 51 87 – DISORDERS OF FETUS AND PREGNANCY 59 88 – PEDIATRIC PATHOLOGY 61 91 – SKIN 63 92 – BONES, JOINTS, AND SOFT TISSUE 67 93 – SKELETAL MUSCLE 69 94 – NERVOUS SYSTEM 71 95 – SPECIAL SENSE ORGANS 79 *Under review as part of a project to develop a comprehensive set of national guidelines for second year pathology students. **Topic number refers to MCA topic designation in the GRIPE question banks. 1 2 GRIPE Systemic Pathology Heart 61 - HEART The student will be able to: 1. Define and use in proper context: anastomosis cor pulmonale myocardial infarct aneurysm coronary artery disease myocarditis angina pectoris dextrocardia pancarditis arrhythmia diastole pericarditis Aschoff body Dressler syndrome Prinzmetal angina beriberi heart disease ductus arteriosus reperfusion injury carcinoid heart Ebstein rheumatic fever disease anomaly/malformation rheumatic heart disease cardiac tamponade endocardial ring abscess cardiogenic shock fibroelastosis stenosis cardiomyopathy endocarditis sudden cardiac death chronic ischemic foramen ovale systole heart disease heart failure tetralogy of Fallot coarctation of the hemopericardium transposition of great aorta hypertension vessels conduction system of hypertensive heart truncus arteriosus the heart disease unstable angina congenital heart hypertrophy of the valvular insufficiency disease myocardium valvular regurgitatioin congestive heart ischemic heart disease valvular stenosis failure Libman-Sacks vegetation contraction band endocarditis verruca necrosis marantic endocarditis cor bovinum mitral valve prolapse 2.
    [Show full text]